CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 379 enrolled
Drug / intervention
Valaciclovirdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01390857
NCT01390857N/ACompleted

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

GlaxoSmithKline·observational·Posted Jul 11, 2011·Updated May 17, 2017

In Brief

An observational study evaluating Valaciclovir for Varicella. Completed, enrolled 379 participants.

Detailed Summary

The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVaricella
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 11, 2011
Enrollment StartNov 1, 2007
Primary CompletionSep 1, 2008
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.0 years ago

Interventions

Valaciclovirdrug